MARKETS
Analyst Actions

HC Wainwright & Co. Reiterates Buy on Verastem, Maintains $18 Price Target

Sep 11, 2026 · 12:47 PM ET· updated 2d ago

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Verastem (NASDAQ:VSTM) with a Buy and maintains $18 price target.

Share
Why It Matters

A stock expert thinks Verastem is worth buying and keeps saying the stock could be worth $18 per share. When experts keep the same opinion, it means they still feel confident about the company's future.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.